Skip to main content

Hurley Ariel's Form 4 filing

Blueprint Medicines Corp (BPMC) · filed Mar 4, 2025

Accession no.
0001415889-25-006608
Filed
Mar 4, 2025
Trade date
Mar 1-3, 2025
Filing delay
3 days
Rule 10b5-1 plan
Checked

This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $296.7K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hurley ArielCIK 0001769740Officer (PRINCIPAL ACCOUNTING OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 1, 2025Common StockAGrant or awardAcquired+6,506$0.00$021,473Direct
Mar 3, 2025Common StockSSaleDisposed−775$89.63−$69,463.2520,698Direct
Mar 3, 2025Common StockSSaleDisposed−238$90.92−$21,638.9620,460Direct
Mar 3, 2025Common StockSSaleDisposed−631$92.00−$58,05219,829Direct
Mar 3, 2025Common StockSSaleDisposed−484$93.42−$45,215.2819,345Direct
Mar 3, 2025Common StockSSaleDisposed−1,075$95.16−$102,29718,270Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 1, 2025Common StockAGrant or awardAcquired+7,007$95.67+$670,359.697,007Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)